Access to medicines
All Topics

Access to medicines

One third of the world lacks  access to essential medicines.  In the poorest parts of Africa and Asia this figure rises to a half of the population. We challenge the high cost of medicines and the absence of treatment for many of the diseases affecting ou

Too often  we cannot treat patients because the medicines are too expensive, or they are no longer produced.  Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure. 
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases. 

 
MSF lab manager Mercy Oluya performs a kala azar diagnostic test MSF laboratory in Abdurafi May 2018
Access to medicines

MSF warns that reduced funding for Neglected Tropical Diseases could be devastating

Press Release 23 Jun 2022
 
Antony, MSF’s health promoter, during an information session in Kario [© MSF/Jinaane Saad]
Access to Healthcare

Sudan: MSF handing over medical activities in Kario refugee camp to Sudanese Ministry of Health

Press Release 22 Jun 2022
 
Access to medicines

German government must push BioNTech to urgently transfer mRNA vaccine technology

Press Release 31 May 2022
 
Access to medicines

MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB

Press Release 4 May 2022
 
Access to medicines

MSF calls on Moderna to transfer mRNA vaccine technology without further delay

Press Release 27 Apr 2022
 
Access to Healthcare

Neither the waiver people need nor a solution fit for a pandemic

4 Apr 2022